Keeping Track: A Busy Week For Regenerative Medicine, A Surprise Priority Review For Vascepa, And Tazemetostat Aims For Accelerated Approval

 
• By Michael Cipriano, Bridget Silverman, and Brenda Sandburg

The latest drug development news and highlights from our US FDA Performance Tracker.

Keeping Track Feature image
The drug development news cycle stayed hot coming out of Memorial Day weekend.

More from Product Reviews

More from Pink Sheet